Verified Nov 2026
Other
·

London, England
·
Since 2018
Theramex is a specialty pharmaceutical company headquartered in London, England, founded in 2018 as a re-establishment of a business dating to 1954. The company employs 500–1,000 people and serves women's health across contraception, fertility, menopause, and osteoporosis treatment. Its portfolio includes approximately 50 products such as Orocal® and Lutenyl®, reaching over six million patients in more than 80 countries.
Theramex at a glance
Revenue
<$10M
Est. band
Employees
500-1,000
Founded
2018
Headquarters
London, England
Industries
Automotive
Electric Vehicles
Medical
Overview
Theramex is a specialty pharmaceutical company headquartered in London, England, founded in 2018 as a re-establishment of a business dating to 1954. The company employs 500–1,000 people and serves women's health across contraception, fertility, menopause, and osteoporosis treatment. Its portfolio includes approximately 50 products such as Orocal® and Lutenyl®, reaching over six million patients in more than 80 countries.
At a glance
Attribute | Detail |
|---|---|
Founded | 2018 |
Headquarters | London, England |
Employees | 500-1,000 |
Revenue | <$10M (estimated) |
What Theramex makes
The company develops and markets prescription medications across four therapeutic areas: contraception, fertility support, menopause management, and osteoporosis treatment.
Latest developments
2026-11-03 — Cinven to acquire Theramex (cinven.com)
2026-11-03 — Carlyle and PAI Partners Agree to Sell Theramex | Carlyle (carlyle.com)
2026-10-07 — Theramex Enters an Exclusive Licensing Agreement with Asieris for CEVIRA® - Theramex (theramex.com)
2026-06-18 — Theramex Announces Strategic Partnership with Viramal to Expand Women’s Health Pipeline - Theramex (theramex.com)
2025-05-16 — Theramex Leverages AlphaSense to Fuel Global Growth and Expansion into New Territories (alpha-sense.com)
2025-02-20 — Daré Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive Implant | Daré Bioscience (darebioscience.com)
Company details
Theramex was acquired by Cinven in November 2026, following ownership by Carlyle and PAI Partners. Theramex was founded in 2018, has an estimated 500-1,000 employees, and is headquartered in London, England.
Frequently asked questions
What does Theramex do?
Theramex is a specialty pharmaceutical company headquartered in London, England, founded in 2018 as a re-establishment of a business dating to 1954. The company employs 500–1,000 people and serves women's health across contraception, fertility, menopause, and osteoporosis treatment. Its portfolio includes approximately 50 products such as Orocal® and Lutenyl®, reaching over six million patients in more than 80 countries.
Where is Theramex headquartered?
Theramex is headquartered in London, England (1 Holbein Place, London, England, SW1W 8NS).
When was Theramex founded?
Theramex was founded in 2018.
How big is Theramex?
Theramex has an estimated 500-1,000 employees, with revenue in the <$10M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
